Silence Therapeutics plc (SLNCF)
OTCMKTS
· Delayed Price · Currency is USD
2.360
0.00 (0.00%)
Apr 27, 2026, 4:00 PM EST
Silence Therapeutics Market Cap
Silence Therapeutics has a market cap or net worth of $363.70 million as of April 28, 2026. Its market cap has increased by 251.67% in one year.
Market Cap
363.70M
Enterprise Value
278.75M
Revenue
559.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$2.36
Market Cap Chart
Since September 8, 2020, Silence Therapeutics's market cap has decreased from 538.37M to 363.70M, a decrease of -32.44%. That is a compound annual growth rate of -6.72%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 330.27M |
| CytoDyn | 408.44M |
| Vaxart | 173.64M |
| Glorywin Entertainment Group | 149.60M |
| Viskase Holdings | 95.20M |
| HST Global | 88.40M |
| BioStem Technologies | 81.91M |
| Nuo Therapeutics | 62.92M |